ID   SC6A5_RAT               Reviewed;         799 AA.
AC   P58295; F1LNM6; Q6QDB3;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   20-JAN-2016, sequence version 2.
DT   02-OCT-2024, entry version 143.
DE   RecName: Full=Sodium- and chloride-dependent glycine transporter 2;
DE            Short=GlyT-2;
DE            Short=GlyT2;
DE   AltName: Full=Solute carrier family 6 member 5;
GN   Name=Slc6a5; Synonyms=Glyt2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A), FUNCTION, TRANSPORTER ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=8226790; DOI=10.1016/s0021-9258(18)41598-0;
RA   Liu Q.-R., Lopez-Corcuera B., Mandiyan S., Nelson H., Nelson N.;
RT   "Cloning and expression of a spinal cord- and brain-specific glycine
RT   transporter with novel structural features.";
RL   J. Biol. Chem. 268:22802-22808(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B).
RC   STRAIN=Sprague-Dawley;
RA   Liu Q.-R., Li Q.-F.;
RT   "Isoforms of sodium dependent type 2 glycine transporter.";
RL   Submitted (FEB-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [5]
RP   MUTAGENESIS OF SER-512, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=25480793; DOI=10.1074/jbc.m114.587055;
RA   Arribas-Gonzalez E., de Juan-Sanz J., Aragon C., Lopez-Corcuera B.;
RT   "Molecular basis of the dominant negative effect of a glycine transporter 2
RT   mutation associated with hyperekplexia.";
RL   J. Biol. Chem. 290:2150-2165(2015).
CC   -!- FUNCTION: Sodium- and chloride-dependent glycine transporter
CC       (PubMed:25480793, PubMed:8226790). Terminates the action of glycine by
CC       its high affinity sodium-dependent reuptake into presynaptic terminals
CC       (PubMed:8226790). May be responsible for the termination of
CC       neurotransmission at strychnine-sensitive glycinergic synapses
CC       (PubMed:8226790). {ECO:0000269|PubMed:25480793,
CC       ECO:0000269|PubMed:8226790}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=chloride(out) + glycine(out) + 3 Na(+)(out) = chloride(in) +
CC         glycine(in) + 3 Na(+)(in); Xref=Rhea:RHEA:70695, ChEBI:CHEBI:17996,
CC         ChEBI:CHEBI:29101, ChEBI:CHEBI:57305;
CC         Evidence={ECO:0000269|PubMed:8226790};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=17 uM for glycine {ECO:0000269|PubMed:8226790};
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:25480793};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=a;
CC         IsoId=P58295-1; Sequence=Displayed;
CC       Name=b;
CC         IsoId=P58295-2; Sequence=VSP_011610;
CC   -!- TISSUE SPECIFICITY: Specifically expressed in spinal cord, brain stem,
CC       and to a lesser extent in the cerebellum. {ECO:0000269|PubMed:8226790}.
CC   -!- PTM: N-glycosylated. {ECO:0000250|UniProtKB:Q9Y345}.
CC   -!- SIMILARITY: Belongs to the sodium:neurotransmitter symporter (SNF) (TC
CC       2.A.22) family. SLC6A5 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L21672; AAS19315.1; -; mRNA.
DR   EMBL; AY547309; AAS49497.1; -; mRNA.
DR   EMBL; AC141159; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   PIR; A48716; A48716.
DR   RefSeq; NP_976079.1; NM_203334.1.
DR   RefSeq; XP_017444218.1; XM_017588729.1.
DR   AlphaFoldDB; P58295; -.
DR   SMR; P58295; -.
DR   STRING; 10116.ENSRNOP00000043665; -.
DR   BindingDB; P58295; -.
DR   ChEMBL; CHEMBL3195; -.
DR   GlyCosmos; P58295; 4 sites, No reported glycans.
DR   GlyGen; P58295; 4 sites.
DR   iPTMnet; P58295; -.
DR   PhosphoSitePlus; P58295; -.
DR   PaxDb; 10116-ENSRNOP00000043665; -.
DR   Ensembl; ENSRNOT00000041950.5; ENSRNOP00000043665.4; ENSRNOG00000031662.5. [P58295-1]
DR   Ensembl; ENSRNOT00055004546; ENSRNOP00055003362; ENSRNOG00055002912. [P58295-1]
DR   Ensembl; ENSRNOT00060002212; ENSRNOP00060001399; ENSRNOG00060001487. [P58295-1]
DR   Ensembl; ENSRNOT00065014491; ENSRNOP00065010849; ENSRNOG00065009070. [P58295-1]
DR   GeneID; 171148; -.
DR   KEGG; rno:171148; -.
DR   UCSC; RGD:621824; rat. [P58295-1]
DR   AGR; RGD:621824; -.
DR   CTD; 9152; -.
DR   RGD; 621824; Slc6a5.
DR   eggNOG; KOG3660; Eukaryota.
DR   GeneTree; ENSGT00940000154963; -.
DR   InParanoid; P58295; -.
DR   OMA; GAPKEMN; -.
DR   OrthoDB; 3084493at2759; -.
DR   TreeFam; TF343812; -.
DR   Reactome; R-RNO-442660; Na+/Cl- dependent neurotransmitter transporters.
DR   PRO; PR:P58295; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000031662; Expressed in cerebellum and 6 other cell types or tissues.
DR   GO; GO:0031045; C:dense core granule; IDA:ARUK-UCL.
DR   GO; GO:0005768; C:endosome; IDA:ARUK-UCL.
DR   GO; GO:0098690; C:glycinergic synapse; IDA:SynGO.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:SynGO.
DR   GO; GO:0015187; F:glycine transmembrane transporter activity; IDA:RGD.
DR   GO; GO:0015375; F:glycine:sodium symporter activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:1903804; P:glycine import across plasma membrane; ISO:RGD.
DR   GO; GO:0015816; P:glycine transport; IDA:RGD.
DR   GO; GO:0098810; P:neurotransmitter reuptake; ISO:RGD.
DR   GO; GO:0001504; P:neurotransmitter uptake; ISO:RGD.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0060012; P:synaptic transmission, glycinergic; ISO:RGD.
DR   CDD; cd11499; SLC6sbd_GlyT2; 1.
DR   InterPro; IPR000175; Na/ntran_symport.
DR   InterPro; IPR037272; SNS_sf.
DR   PANTHER; PTHR11616:SF315; SODIUM- AND CHLORIDE-DEPENDENT GLYCINE TRANSPORTER 2; 1.
DR   PANTHER; PTHR11616; SODIUM/CHLORIDE DEPENDENT TRANSPORTER; 1.
DR   Pfam; PF00209; SNF; 1.
DR   PRINTS; PR00176; NANEUSMPORT.
DR   SUPFAM; SSF161070; SNF-like; 1.
DR   PROSITE; PS00610; NA_NEUROTRAN_SYMP_1; 1.
DR   PROSITE; PS00754; NA_NEUROTRAN_SYMP_2; 1.
DR   PROSITE; PS50267; NA_NEUROTRAN_SYMP_3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Disulfide bond; Glycoprotein;
KW   Membrane; Metal-binding; Neurotransmitter transport; Phosphoprotein;
KW   Reference proteome; Sodium; Symport; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN           1..799
FT                   /note="Sodium- and chloride-dependent glycine transporter
FT                   2"
FT                   /id="PRO_0000214764"
FT   TOPO_DOM        1..201
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        202..222
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        230..249
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        273..293
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        294..395
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        396..414
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        423..440
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        476..493
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        505..526
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        559..578
FT                   /note="Helical; Name=8"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        606..624
FT                   /note="Helical; Name=9"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        640..660
FT                   /note="Helical; Name=10"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        681..700
FT                   /note="Helical; Name=11"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        719..737
FT                   /note="Helical; Name=12"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        738..799
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          1..64
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         208
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q7K4Y6"
FT   BINDING         210
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q7K4Y6"
FT   BINDING         211
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q7K4Y6"
FT   BINDING         215
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q7K4Y6"
FT   BINDING         479
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q7K4Y6"
FT   BINDING         511
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q7K4Y6"
FT   BINDING         576
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q7K4Y6"
FT   BINDING         579
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q7K4Y6"
FT   MOD_RES         58
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         59
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q761V0"
FT   MOD_RES         86
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q761V0"
FT   CARBOHYD        345
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        355
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        360
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        366
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        313..322
FT                   /evidence="ECO:0000250|UniProtKB:Q7K4Y6"
FT   VAR_SEQ         1..8
FT                   /note="Missing (in isoform b)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_011610"
FT   MUTAGEN         512
FT                   /note="S->A: Decreased glycine transport."
FT                   /evidence="ECO:0000269|PubMed:25480793"
FT   MUTAGEN         512
FT                   /note="S->C: Decreased glycine transport."
FT                   /evidence="ECO:0000269|PubMed:25480793"
FT   MUTAGEN         512
FT                   /note="S->R: Loss of glycine transport. Retained in the
FT                   endoplasmic reticulum due to defective processing and
FT                   trafficking to the cell surface."
FT                   /evidence="ECO:0000269|PubMed:25480793"
FT   MUTAGEN         512
FT                   /note="S->T: No effect on glycine transport."
FT                   /evidence="ECO:0000269|PubMed:25480793"
FT   CONFLICT        139
FT                   /note="G -> A (in Ref. 1; AAS19315 and 2; AAS49497)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        150
FT                   /note="A -> P (in Ref. 1; AAS19315 and 2; AAS49497)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        399
FT                   /note="A -> P (in Ref. 1; AAS19315 and 2; AAS49497)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   799 AA;  87842 MW;  5F0D87B3D2DBE662 CRC64;
     MDCSAPKEMN KPPTNILEAT VPGHRDSPRA PRTSPEQDLP AAAPAAAVQP PRVPRSASTG
     AQTFQSADAR ACEAQRPGVG FCKLSSPQAQ ATSAALRDLS EGHSAQANPP SGAAGAGNAL
     HCKIPALRGP EEDENVSVGK GTLEHNNTPA VGWVNMSQST VVLGTDGIAS VLPGSVATTT
     IPEDEQGDEN KARGNWSSKL DFILSMVGYA VGLGNVWRFP YLAFQNGGGA FLIPYLMMLA
     LAGLPIFFLE VSLGQFASQG PVSVWKAIPA LQGCGIAMLI ISVLIAIYYN VIICYTLFYL
     FASFVSVLPW GSCNNPWNTP ECKDKTKLLL DSCVIGDHPK IQIKNSTFCM TAYPNLTMVN
     FTSQANKTFV SGSEEYFKYF VLKISAGIEY PGEIRWPLAF CLFLAWVIVY ASLAKGIKTS
     GKVVYFTATF PYVVLVILLI RGVTLPGAGA GIWYFITPKW EKLTDATVWK DAATQIFFSL
     SAAWGGLITL SSYNKFHNNC YRDTLIVTCT NSATSIFAGF VIFSVIGFMA NERKVNIENV
     ADQGPGIAFV VYPEALTRLP LSPFWAIIFF LMLLTLGLDT MFATIETIVT SISDEFPKYL
     RTHKPVFTLG CCICFFIMGF PMITQGGIYM FQLVDTYAAS YALVIIAIFE LVGISYVYGL
     QRFCEDIEMM IGFQPNIFWK VCWAFVTPTI LTFILCFSFY QWEPMTYGSY RYPNWSMVLG
     WLMLACSVIW IPIMFVIKMY LAPGRFIERL KLVCSPQPDW GPFLAQHRGE RYKNMIDPLG
     TSSLGLKLPV KDLELGTQC
//
